Get startedLog in
    Picture of Actinium Pharmaceuticals logo

    ATNM — Actinium Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMicro CapSucker Stock
    All News

    Brief: Actinium Gets FDA Clearance of Iomab-ACT Targeted Conditioning IND Application

    Picture of Actinium Pharmaceuticals logoActinium Pharmaceuticals
    25/07/2024 14:00
    July 25 (Reuters) - Actinium Pharmaceuticals Inc
 ATNM.A :
    * ACTINIUM ANNOUNCES FDA CLEARANCE OF IOMAB-ACT TARGETED
CONDITIONING IND APPLICATION FOR SICKLE CELL DISEASE PATIENTS
UNDERGOING BONE MARROW TRANSPLANT IN COLLABORATION WITH COLUMBIA
UNIVERSITY

Source text for Eikon:  ID:nPn78sbDpa 
Further company coverage:  ATNM.A 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Actinium Pharmaceuticals

    See all news